Subject List - Pharmaceutical Executive

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Site Content

ADVERTISEMENT

Pharm Exec's 2014 Dealmakers Outlook
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
European Pharma Races to Catch Up with Data Protection
Pharma Rep Access Down 33 Per Cent Since 2008
Shire Takeover "Could Save AbbVie $8 Billion Tax on Humira over Next 15 Years"
PHARM EXEC DIGEST EUROPE
Pharmaceutical Executive Digest EuropeTo read the latest issue of Pharm Exec Global Digest
Click here. Click here to receive the Digest into your inbox every month.
SURVEY
The FDA Safety & Innovation Act (FDASIA) was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Click here